OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

MTR Corp Ltd/  HK0066009694  /

Hong Kong SE
2024-07-29  12:00:00 AM Chg. +0.10 Volume Bid10:08:07 AM Ask10:08:07 AM Market Capitalization Dividend Y. P/E Ratio
25.25HKD +0.40% 3.16 mill.
Turnover: 72.58 mill.		 25.25Bid Size: - 25.30Ask Size: - 156.6 bill.HKD 5.19% 15.88
Newsfile Corp 04-26 Winner of Hong Kong's Flagship Global Elevator Pitch Competition Crowned
GlobeNewswire 04-16 Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Pres...
GlobeNewswire 04-10 ROHM’s New Linear Op Amp Features Industry-Low 160nA Current Consumption
GlobeNewswire 03-26 Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Cl...
GlobeNewswire 03-07 Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
Newsfile Corp 01-19 Silicon Valley's Finest Startups Set to Ride HKSTP Elevator Pitch Competition 2024 to Asia and the W...
Newsfile Corp 2023-11-24 Dorsett Wanchai, Hong Kong Recognized for Sustainable Excellence and Exceptional Service
GlobeNewswire 2022-03-21 Telix Radiopharmaceutical Production Facility Buildout Commences
GlobeNewswire 2022-03-21 EAU Updates Guidance for PSMA-PET Imaging
GlobeNewswire 2022-03-08 Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentati...
GlobeNewswire 2022-03-07 ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
GlobeNewswire 2022-03-01 Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-18 Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
GlobeNewswire 2022-02-10 Telix and SHINE partner for Lutetium-177 Supply
GlobeNewswire 2022-02-08 Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
GlobeNewswire 2022-01-27 Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
GlobeNewswire 2022-01-26 First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
GlobeNewswire 2022-01-25 Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
GlobeNewswire 2021-12-22 Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
GlobeNewswire 2021-12-20 First Patient Dosed in Study of Targeted Alpha Therapy Candidate for Bladder Cancer
GlobeNewswire 2021-12-19 FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
GlobeNewswire 2021-12-14 Embily Launches Support For DAI and USD Coin
GlobeNewswire 2021-12-07 Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
GlobeNewswire 2021-12-01 Sophos Named Security Vendor of the Year
GlobeNewswire 2021-11-30 Illuccix® Granted Use Authorisation for Prostate Cancer Imaging in Brazil